No Data
No Data
shanghai fudan-zhangjiang bio-pharmaceutical co. ltd. (01349.HK) subscribed to 0.2 billion yuan shanghai pudong development bank structured deposit products
On October 10, Ge Longhui announced that on October 10, 2024, Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co. Ltd. (01349.HK) signed a structured deposit product agreement with Shanghai Pudong Development Bank, agreeing to subscribe to a total amount of RMB 0.2 billion in structured deposit products using idle funds generated from daily operations.
Shanghai Pudong Development Bank (600000.SH): Xie Wei appointed as the company's President.
Gelonghui October 7th | Shanghai Pudong Development Bank (600000.SH) announced that on September 30, the company received the "Reply from the China Banking Regulatory Commission on the Qualification of Xie Wei, President of Shanghai Pudong Development Bank" (Jin Fu [2024] No. 642). The China Banking Regulatory Commission has approved Mr. Xie Wei's qualification as the president of the company. Xie Wei took office as the president of the company on September 30, 2024.
Huafu Securities: The reduction of existing home loan interest rates has finally been implemented. Three factors are driving the banks sector.
Banks sector needs to further examine the effects of previous policies and the future trend of the fundamentals.
China Longyuan Power Issues 2 Billion Yuan Bond
Huafu Securities reviews the interim data of 42 listed banks: stable profit growth and strengthened investment logic in high dividend stocks.
The revenue growth rate is slowing down marginally, while the profit growth rate remains relatively stable.
Shanghai Pudong Development Bank, Shanghai Branch, Gao Jianbing: Serving the scientific and technological innovation field, the transformation of bank institutions is happening at the right time.
① Service technology enterprises are listed as the first track of the Shanghai Pudong Development Bank. ② There are still challenges in understanding and evaluating the technology of technology enterprises during the loan process, and further discussions are needed on guarantee measures and risk management.
No Data
No Data